Outcomes of patients from restricted (Group 1) and non-restricted (Group 2) COVID-19 period with newly diagnosed nAMD of the first eye who have received aflibercept 2mg injections only.
收藏数据链接：
官方服务：
资源简介：
Outcomes of patients from restricted (Group 1) and non-restricted (Group 2) COVID-19 period with newly diagnosed nAMD of the first eye who have received aflibercept 2mg injections only.
创建时间：
2025-05-07
